CircCNST facilitated the proliferation and colony formation of OS cells. (A) Schematic representation of target sequences of the shRNA specific to the back-splicing junction of circCNST. (B) qRT-PCR analysis of the expression levels of circCNST in different OS cell lines. (C) qRT-PCR analysis of the transfection efficiency of circCNST plasmid in SW-1353 and MG-63 cell lines or sh-circCNST in HOS and U-2OS cell lines. (D, E) 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide analysis of the cell viability after the transfection with circCNST plasmid in SW-1353 and MG-63 cell lines or sh-circCNST in HOS and U-2OS cell lines. (F, G) Colony formation analysis of the cell colony number after the transfection with circCNST plasmid in SW-1353 and MG-63 cell lines or sh-circCNST in HOS and U-2OS cell lines. Data are the means ± standard error of the mean of three experiments. *P < 0.05, **P < 0.01. CNST: consortin; OS: osteosarcoma; qRT-PCR: quantitative real-time polymerase chain reaction.